Angelini Pharma Polska Sp. z o.o.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.
ANGELINI PHARMA
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.
Angelini Pharma Deutschland GmbH
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.
Savencia Fromage & Dairy UK
Savencia Fromage & Dairy UK specialises in the distribution of Continental Cheese (Branded and Own Label) to major UK retailers. We are also experts in Cheese Education and train our customers through our Ecole du Fromage. We have two sites: a cut & wrap factory in Westbury, Wiltshire and the Marketing & Commercial office based in Kingston.
Our 3 main brands in the UK are Saint Agur , Le Rustique and Chavroux.
ING Bank N.V., London branch
ING’s Wholesale Banking business is located in the heart of the UK’s financial district, the City of London. As one of over 200 foreign banks in London, we attract the finest financial professionals. ING has a long history of serving clients, dating back to the establishment of Barings Bank in 1762. This experience gives us a unique advantage known as the “ING Difference”. Our worldwide reach, combined with local experts, allows us to provide clients with a seamless local experience with a global view. At the same time, our expertise in various sectors earns the trust of our clients, who rely on us to deliver solutions tailored to their specialist needs. Lastly, our commitment to sustainability sets us apart as pioneers in the industry, working with clients to help them achieve their sustainability goals.
Becton Dickinson Polska Sp. z o.o.
BD is one of the world’s largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare.